4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-057604
President sold 33,618 shares at $70.00 ($2,353,260)
- President acquired 33,618 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2019-11-19 | Option exercise | +33,618 | $14.43 | $485,108 | 33,618 | D |
| Novak Rodger President | 2019-11-19 | Sale | −33,618 | $70.00 | $2,353,260 | 0 | D |
| Derivatives | |||||||
| Novak Rodger President | 2019-11-19 | Option exercise · Stock Option (Right to Buy) | −33,618 | 236,382 | D | ||
| Open-market sales · 33,618 sh · avg $70.00 · $2,353,260 | |||||||
Loading xslF345X03/doc4.xml…